Many A, Schwartz R S
Clin Exp Immunol. 1970 Jan;6(1):87-99.
The mechanism of immunological tolerance of sheep red blood cells (SRBC) in mice treated with a single dose of cyclophosphamide was studied. Specific tolerance lasted for as long as nine months in some animals, and its maintenance required the repeated administration of SRBC. Anti-SRBC antibody-forming cells were significantly reduced in the tolerant mice, and X-irradiated recipients of their spleens were specifically tolerant of SRBC. The smallest number of SRBC required for the induction of tolerance was 10; this was the smallest number of SRBC that could elicit antibody synthesis within 5 days in normal mice. Since the effects of cyclophosphamide on antibody-forming cells last only 5 days, it was concluded that the mechanism of tolerance induction involved destruction of antigen-stimulated cells. In support of this is the finding that mice treated with small doses of cyclophosphamide were rendered tolerant only when SRBC were given before the drug. Drug-induced immunological tolerance thus appears to differ significantly from both pneumococcal polysaccharide paralysis and classical, acquired tolerance. A central loss of immunocompetence does not occur in the former, while the latter requires for its induction the administration of antigen in a dose or form that does not stimulate antibody synthesis.
研究了用单剂量环磷酰胺处理的小鼠对绵羊红细胞(SRBC)的免疫耐受机制。在一些动物中,特异性耐受持续长达九个月,其维持需要反复给予SRBC。耐受小鼠中抗SRBC抗体形成细胞显著减少,其脾脏经X射线照射的受体对SRBC具有特异性耐受。诱导耐受所需的SRBC最小数量为10;这是在正常小鼠中5天内可引发抗体合成的SRBC最小数量。由于环磷酰胺对抗体形成细胞的作用仅持续5天,因此得出结论,耐受诱导机制涉及抗原刺激细胞的破坏。支持这一点的是以下发现:仅在给药前给予SRBC时,用小剂量环磷酰胺处理的小鼠才会产生耐受。因此,药物诱导的免疫耐受似乎与肺炎球菌多糖麻痹和经典的获得性耐受均有显著差异。前者不会发生免疫活性的中心丧失,而后者的诱导需要给予不刺激抗体合成的剂量或形式的抗原。